NRO Neurones SA

NEURONES : +4.2% organic growth in the 1st quarter 2019

NEURONES : +4.2% organic growth in the 1st quarter 2019

PRESS INFORMATION

Nanterre, 15 May 2019 (after the closing of the stock exchange)

Heading: Revenues 1st quarter 2019

+4.2% organic growth in the 1st quarter 2019

(in millions of euros)Q1 2018Q1 2019growthof which organic
Revenues (¹)124.1128.7+3.7%+4.2%

Achievements

In the first quarter of 2019, the Group achieved 4.2% organic growth. Over the period, after the high point for financial year 2018, employee turnover began to decline.

The operating profit (¹) (²) for the quarter totaled 9.5% of revenues vs. 8.4% one year earlier.

Compared to the 2018 reference document (available at ), the financial situation did not experience any significant changes.

Outlook

In its current scope, NEURONES forecasts the following for 2019:

  • close to €505 million in revenues,
  • an operating profit (²) of between 9% and 9.5% of revenues.

(¹) Unaudited and after inclusion of 0.1% expenses related to bonus shares.

(²) These figures do not include the consolidated capital gain (+ €4.6 million) realized at the end of January 2019, on the occasion of the sale of an activity representing annual revenues of €5.3 million. The operating profit (IFRS) for the 1st quarter is therefore 13% and the forecast for financial year 2019 is increased by approximately 0.9% of revenues.

About NEURONES

With 5,200 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and Digital Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values



 Investor Relations:

NEURONES

Paul-César Bonnel

Tel: +33 (0)1 41 37 41 37



Press Relations:

NEURONES

Matthieu Vautier

Tel: +33 (0)1 41 37 41 37



Attachment

EN
15/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: 5.1% organic growth in 2025

NEURONES: 5.1% organic growth in 2025 PRESS INFORMATIONHeading: 2025 annual revenues        Nanterre, February 11, 2026 (after trading) 5.1% organic growth in 2025 (being audited, in € millions)20242025Growthof which organic4rd quarter revenues211.3225+ 6.5%+ 6.2%Annual revenues810.4857.2+ 5.8%+ 5.1% Achievements NEURONES closes the financial year with annual revenue of €857.2 million, exceeding its expectations. Growth is driven by digital and data projects (double-digit growth), while AI-related activities confirm a promising upward trend. With its decentralized and responsive structu...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique en 2025

NEURONES : + 5,1% de croissance organique en 2025 INFORMATION PRESSERubrique : C.A. annuel 2025        Nanterre, le 11 février 2026 (après Bourse) + 5,1% de croissance organique en 2025 (en cours d’audit, en M€)20242025Croissancedont organiqueChiffre d’affaires 4e trimestre211,3225+ 6,5%+ 6,2%Chiffre d’affaires annuel810,4    857,2+ 5,8%+ 5,1% Réalisations NEURONES clôture l’exercice avec un chiffre d’affaires annuel de 857,2 M€, dépassant ainsi ses anticipations. La croissance est portée par les projets digitaux et data (progression à deux chiffres), tandis que les activités liées à l’I...

 PRESS RELEASE

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch